(e,e,e,e)-squalene

(e,e,e,e)-squalene is a lipid of Fatty Acyls (FA) class. (e,e,e,e)-squalene is associated with abnormalities such as Hypercholesterolemia and Cataract. The involved functions are known as Process, metaplastic cell transformation, Protein Overexpression, Anabolism and Biosynthetic Pathways. (e,e,e,e)-squalene often locates in Membrane, Protoplasm, Plasma membrane, Tissue membrane and Back. The associated genes with (e,e,e,e)-squalene are Genome, IMPACT gene, GAPDH gene, GTF2I gene and Chromatin. The related lipids are Membrane Lipids, cycloartenol, Sterols, Fatty Acids and Nonesterified Fatty Acids.

Cross Reference

Introduction

To understand associated biological information of (e,e,e,e)-squalene, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with (e,e,e,e)-squalene?

(e,e,e,e)-squalene is suspected in Hypercholesterolemia, Cataract and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with (e,e,e,e)-squalene

MeSH term MeSH ID Detail
Fatigue D005221 10 associated lipids
Photosensitivity Disorders D010787 8 associated lipids
Fibrosarcoma D005354 8 associated lipids
Chondrodysplasia Punctata D002806 8 associated lipids
Chronic Disease D002908 7 associated lipids
Alopecia Areata D000506 6 associated lipids
Leukemia, Hairy Cell D007943 5 associated lipids
Parasitemia D018512 5 associated lipids
Tinea Versicolor D014010 5 associated lipids
Keratitis, Herpetic D016849 5 associated lipids
Per page 10 20 50 100 | Total 84

PubChem Associated disorders and diseases

What pathways are associated with (e,e,e,e)-squalene

There are no associated biomedical information in the current reference collection.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with (e,e,e,e)-squalene?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with (e,e,e,e)-squalene?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with (e,e,e,e)-squalene?

Related references are published most in these journals:

Lipid concept Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What genes are associated with (e,e,e,e)-squalene?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with (e,e,e,e)-squalene?

There are no associated biomedical information in the current reference collection.

NCBI Entrez Crosslinks

All references with (e,e,e,e)-squalene

Download all related citations
Per page 10 20 50 100 | Total 1766
Authors Title Published Journal PubMed Link
Bhilwade HN et al. Squalene as novel food factor. 2010 Curr Pharm Biotechnol pmid:20874681
Iannitti T and Palmieri B An update on the therapeutic role of alkylglycerols. 2010 Mar Drugs pmid:20948908
Fragapane E et al. A heterologous MF59-adjuvanted H5N1 prepandemic influenza booster vaccine induces a robust, cross-reactive immune response in adults and the elderly. 2010 Clin. Vaccine Immunol. pmid:20810680
Esposito S et al. Immunogenicity, safety and tolerability of monovalent 2009 pandemic influenza A/H1N1 MF59-adjuvanted vaccine in patients with β-thalassemia major. 2010 Vaccine pmid:20888873
Khurana S et al. Vaccines with MF59 adjuvant expand the antibody repertoire to target protective sites of pandemic avian H5N1 influenza virus. 2010 Sci Transl Med pmid:20371470
Lippi G et al. Vaccination, squalene and anti-squalene antibodies: facts or fiction? 2010 Eur. J. Intern. Med. pmid:20206873
Barnett SW et al. Antibody-mediated protection against mucosal simian-human immunodeficiency virus challenge of macaques immunized with alphavirus replicon particles and boosted with trimeric envelope glycoprotein in MF59 adjuvant. 2010 J. Virol. pmid:20392857
Caron J et al. Squalenoyl nucleoside monophosphate nanoassemblies: new prodrug strategy for the delivery of nucleotide analogues. 2010 Bioorg. Med. Chem. Lett. pmid:20363623
Xiong Z et al. A short total synthesis of (+)-omaezakianol via an epoxide-initiated cationic cascade reaction. 2010 Org. Lett. pmid:20218639
Durando P et al. MF59-adjuvanted vaccine: a safe and useful tool to enhance and broaden protection against seasonal influenza viruses in subjects at risk. 2010 Expert Opin Biol Ther pmid:20218923
Taramino S et al. Interactions of oxidosqualene cyclase (Erg7p) with 3-keto reductase (Erg27p) and other enzymes of sterol biosynthesis in yeast. 2010 Biochim. Biophys. Acta pmid:19879375
van Himbergen TM et al. Familial combined hyperlipidemia is associated with alterations in the cholesterol synthesis pathway. 2010 Arterioscler. Thromb. Vasc. Biol. pmid:19834104
Keitel W et al. Dose ranging of adjuvant and antigen in a cell culture H5N1 influenza vaccine: safety and immunogenicity of a phase 1/2 clinical trial. 2010 Vaccine pmid:19835829
Brunner R et al. The ABC of clinical and experimental adjuvants--a brief overview. 2010 Immunol. Lett. pmid:19895847
Eroglu E and Melis A Extracellular terpenoid hydrocarbon extraction and quantitation from the green microalgae Botryococcus braunii var. Showa. 2010 Bioresour. Technol. pmid:20005092
Kalvodova L Squalene-based oil-in-water emulsion adjuvants perturb metabolism of neutral lipids and enhance lipid droplet formation. 2010 Biochem. Biophys. Res. Commun. pmid:20018176
Xiao L et al. The effect of squalane-dissolved fullerene-C60 on adipogenesis-accompanied oxidative stress and macrophage activation in a preadipocyte-monocyte co-culture system. 2010 Biomaterials pmid:20488530
Carmona A et al. Immunogenicity and safety of AS03-adjuvanted 2009 influenza A H1N1 vaccine in children 6-35 months. 2010 Vaccine pmid:20600478
Caligiani A et al. Characterization of a potential nutraceutical ingredient: pomegranate (Punica granatum L.) seed oil unsaponifiable fraction. 2010 Plant Foods Hum Nutr pmid:20607413
Zhao RY et al. Cloning and characterization of squalene synthase gene from Fusarium fujikuroi (Saw.) Wr. 2010 J. Ind. Microbiol. Biotechnol. pmid:20585832
Yasuda Y et al. Comparison of half and full doses of an MF59-adjuvanted cell culture-derived A/H1N1v vaccine in Japanese children. 2010 Adv Ther pmid:20586002
Frey SE et al. Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults. 2010 Vaccine pmid:20619382
Dosio F et al. Novel nanoassemblies composed of squalenoyl-paclitaxel derivatives: synthesis, characterization, and biological evaluation. 2010 Bioconjug. Chem. pmid:20597546
Sarpietro MG et al. Interaction of acyclovir and its squalenoyl-acyclovir prodrug with DMPC in monolayers at the air/water interface. 2010 Int J Pharm pmid:20635474
Wohlrab J et al. Interaction of epicutaneously applied lipids with stratum corneum depends on the presence of either emulsifiers or hydrogenated phosphatidylcholine. 2010 Skin Pharmacol Physiol pmid:20523109
Koohang A et al. Enantioselective inhibition of squalene synthase by aziridine analogues of presqualene diphosphate. 2010 J. Org. Chem. pmid:20545375
Camin F et al. Stable isotope ratios of carbon and hydrogen to distinguish olive oil from shark squalene-squalane. 2010 Rapid Commun. Mass Spectrom. pmid:20499327
Mantzouridou F and Tsimidou MZ Observations on squalene accumulation in Saccharomyces cerevisiae due to the manipulation of HMG2 and ERG6. 2010 FEMS Yeast Res. pmid:20550581
Van Damme P et al. Evaluation of non-inferiority of intradermal versus adjuvanted seasonal influenza vaccine using two serological techniques: a randomised comparative study. 2010 BMC Infect. Dis. pmid:20504306
Waddington CS et al. Safety and immunogenicity of AS03B adjuvanted split virion versus non-adjuvanted whole virion H1N1 influenza vaccine in UK children aged 6 months-12 years: open label, randomised, parallel group, multicentre study. 2010 BMJ pmid:20508026
Beck F et al. Queries about vaccines containing squalene. 2010 Immunol. Cell Biol. pmid:20157330
Gerpe A et al. Naftifine-analogues as anti-Trypanosoma cruzi agents. 2010 Eur J Med Chem pmid:20163894
Warleta F et al. Squalene protects against oxidative DNA damage in MCF10A human mammary epithelial cells but not in MCF7 and MDA-MB-231 human breast cancer cells. 2010 Food Chem. Toxicol. pmid:20138105
Sugihara N et al. Novel fractionation method for squalene and phytosterols contained in the deodorization distillate of rice bran oil. 2010 J Oleo Sci pmid:20103978
Chen CC et al. Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: physicochemical characterization and pharmacokinetics. 2010 Eur J Pharm Biopharm pmid:20060469
Spanova M et al. Effect of lipid particle biogenesis on the subcellular distribution of squalene in the yeast Saccharomyces cerevisiae. 2010 J. Biol. Chem. pmid:20032462
Tsai T et al. Exposure to MF59-adjuvanted influenza vaccines during pregnancy--a retrospective analysis. 2010 Vaccine pmid:19969117
Narayan BH et al. Modulation of doxorubicin-induced genotoxicity by squalene in Balb/c mice. 2010 Food Funct pmid:21776469
Bildstein L et al. Transmembrane diffusion of gemcitabine by a nanoparticulate squalenoyl prodrug: an original drug delivery pathway. 2010 J Control Release pmid:20691740
Weiss TL et al. Raman spectroscopy analysis of botryococcene hydrocarbons from the green microalga Botryococcus braunii. 2010 J. Biol. Chem. pmid:20705610
Kato S et al. Clinical evaluation of fullerene-C60 dissolved in squalane for anti-wrinkle cosmetics. 2010 J Nanosci Nanotechnol pmid:21137794
Lin FY et al. Mechanism of action and inhibition of dehydrosqualene synthase. 2010 Proc. Natl. Acad. Sci. U.S.A. pmid:21098670
Ali NA et al. Essential oil composition of leaves of Stachys yemenensis obtained by supercritical COâ‚‚. 2010 Nat. Prod. Res. pmid:21104527
Walker WT and Faust SN Monovalent inactivated split-virion AS03-adjuvanted pandemic influenza A (H1N1) vaccine. 2010 Expert Rev Vaccines pmid:21105775
El Sahly H MF59™ as a vaccine adjuvant: a review of safety and immunogenicity. 2010 Expert Rev Vaccines pmid:20923265
Waddington C et al. Open-label, randomised, parallel-group, multicentre study to evaluate the safety, tolerability and immunogenicity of an AS03(B)/oil-in-water emulsion-adjuvanted (AS03(B)) split-virion versus non-adjuvanted whole-virion H1N1 influenza vaccine in UK children 6 months to 12 years of age. 2010 Health Technol Assess pmid:20923610
Reddy LH et al. Anticancer efficacy of squalenoyl gemcitabine nanomedicine on 60 human tumor cell panel and on experimental tumor. 2009 Sep-Oct Mol. Pharm. pmid:19634915
Huang MH et al. Enhancement of potent antibody and T-cell responses by a single-dose, novel nanoemulsion-formulated pandemic influenza vaccine. 2009 May-Jun Microbes Infect. pmid:19344782
Kopena R et al. Lipophilic compounds from the femoral gland secretions of male Hungarian green lizards, Lacerta viridis. 2009 May-Jun Z. Naturforsch., C, J. Biosci. pmid:19678551
Seiki S and Frishman WH Pharmacologic inhibition of squalene synthase and other downstream enzymes of the cholesterol synthesis pathway: a new therapeutic approach to treatment of hypercholesterolemia. 2009 Mar-Apr Cardiol Rev pmid:19367148
Huang ZR et al. Biological and pharmacological activities of squalene and related compounds: potential uses in cosmetic dermatology. 2009 Molecules pmid:19169201
Banzhoff A et al. MF59-adjuvanted H5N1 vaccine induces immunologic memory and heterotypic antibody responses in non-elderly and elderly adults. 2009 PLoS ONE pmid:19197383
Tritto E et al. Mechanism of action of licensed vaccine adjuvants. 2009 Vaccine pmid:19200813
Ansaldi F et al. Adjuvanted seasonal influenza vaccines and perpetual viral metamorphosis: the importance of cross-protection. 2009 Vaccine pmid:19200846
Galli G et al. Adjuvanted H5N1 vaccine induces early CD4+ T cell response that predicts long-term persistence of protective antibody levels. 2009 Proc. Natl. Acad. Sci. U.S.A. pmid:19237568
Lambrecht BN et al. Mechanism of action of clinically approved adjuvants. 2009 Curr. Opin. Immunol. pmid:19246182
Morimoto Y et al. Total synthesis and determination of the absolute configuration of (+)-omaezakianol. 2009 Angew. Chem. Int. Ed. Engl. pmid:19248063
Burke B et al. Neutralizing antibody responses to subtype B and C adjuvanted HIV envelope protein vaccination in rabbits. 2009 Virology pmid:19249806
Baudner BC et al. MF59 emulsion is an effective delivery system for a synthetic TLR4 agonist (E6020). 2009 Pharm. Res. pmid:19255727
Radak BK et al. Modeling reactive scattering of F(2P) at a liquid squalane interface: a hybrid QM/MM molecular dynamics study. 2009 J Phys Chem A pmid:19323516
Kato S et al. Biological safety of LipoFullerene composed of squalane and fullerene-C60 upon mutagenesis, photocytotoxicity, and permeability into the human skin tissue. 2009 Basic Clin. Pharmacol. Toxicol. pmid:19371265
Campagnac E et al. Fenpropimorph slows down the sterol pathway and the development of the arbuscular mycorrhizal fungus Glomus intraradices. 2009 Mycorrhiza pmid:19340463
Cheng J and Hoshino T Cyclization cascade of the C33-bisnorheptaprenoid catalyzed by recombinant squalene cyclase. 2009 Org. Biomol. Chem. pmid:19343258
Seelert H et al. From protons to OXPHOS supercomplexes and Alzheimer's disease: structure-dynamics-function relationships of energy-transducing membranes. 2009 Biochim. Biophys. Acta pmid:19281792
Uchida H et al. Cloning and characterization of a squalene synthase gene from a petroleum plant, Euphorbia tirucalli L. 2009 Planta pmid:19283408
Sarpietro MG et al. Conjugation of squalene to acyclovir improves the affinity for biomembrane models. 2009 Int J Pharm pmid:19686827
Pellegrini M et al. MF59-adjuvanted versus non-adjuvanted influenza vaccines: integrated analysis from a large safety database. 2009 Vaccine pmid:19751689
Ryu A et al. Squalene as a target molecule in skin hyperpigmentation caused by singlet oxygen. 2009 Biol. Pharm. Bull. pmid:19721223
Clark TW et al. Trial of 2009 influenza A (H1N1) monovalent MF59-adjuvanted vaccine. 2009 N. Engl. J. Med. pmid:19745215
Ghimire GP et al. Improved squalene production via modulation of the methylerythritol 4-phosphate pathway and heterologous expression of genes from Streptomyces peucetius ATCC 27952 in Escherichia coli. 2009 Appl. Environ. Microbiol. pmid:19767465
Shabtay A et al. The potential of Pleurotus-treated olive mill solid waste as cattle feed. 2009 Bioresour. Technol. pmid:19683915
Pedroso N et al. Modulation of plasma membrane lipid profile and microdomains by H2O2 in Saccharomyces cerevisiae. 2009 Free Radic. Biol. Med. pmid:19027845
Laitinen K et al. Plant stanol ester spreads as components of a balanced diet for pregnant and breast-feeding women: evaluation of clinical safety. 2009 Br. J. Nutr. pmid:19017423
Godio RP and Martín JF Modified oxidosqualene cyclases in the formation of bioactive secondary metabolites: biosynthesis of the antitumor clavaric acid. 2009 Fungal Genet. Biol. pmid:19130892
Wertz PW Human synthetic sebum formulation and stability under conditions of use and storage. 2009 Int J Cosmet Sci pmid:19134124
Matyas GR et al. Lipid binding properties of 4E10, 2F5, and WR304 monoclonal antibodies that neutralize HIV-1. 2009 Biochim. Biophys. Acta pmid:19100711
Ghimire GP et al. Squalene-hopene cyclase (Spterp25) from Streptomyces peucetius: sequence analysis, expression and functional characterization. 2009 Biotechnol. Lett. pmid:19116691
Alam MM et al. Phase behavior, formation, and rheology of cubic phase and related gel emulsion in Tween 80/water/oil systems. 2009 J Oleo Sci pmid:19491531
Herchi W et al. Characterization and quantification of the aliphatic hydrocarbon fraction during linseed development ( Linum usitatissimum L.). 2009 J. Agric. Food Chem. pmid:19492811
Cho S et al. High-dose squalene ingestion increases type I procollagen and decreases ultraviolet-induced DNA damage in human skin in vivo but is associated with transient adverse effects. 2009 Clin. Exp. Dermatol. pmid:19522983
Petrick L and Dubowski Y Heterogeneous oxidation of squalene film by ozone under various indoor conditions. 2009 Indoor Air pmid:19500173
Tokuhiro K et al. Overproduction of geranylgeraniol by metabolically engineered Saccharomyces cerevisiae. 2009 Appl. Environ. Microbiol. pmid:19592534
Pass RF Development and evidence for efficacy of CMV glycoprotein B vaccine with MF59 adjuvant. 2009 J. Clin. Virol. pmid:19647480
Forrest HL et al. Single- and multiple-clade influenza A H5N1 vaccines induce cross protection in ferrets. 2009 Vaccine pmid:19406182
López P and Martín J Potential chemosignals associated with male identity in the amphisbaenian Blanus cinereus. 2009 Chem. Senses pmid:19406874
Al-Edresi S and Baie S Formulation and stability of whitening VCO-in-water nano-cream. 2009 Int J Pharm pmid:19429303
Camilloni B et al. Cross-reactive antibodies in middle-aged and elderly volunteers after MF59-adjuvanted subunit trivalent influenza vaccine against B viruses of the B/Victoria or B/Yamagata lineages. 2009 Vaccine pmid:19410623
Galli G et al. Fast rise of broadly cross-reactive antibodies after boosting long-lived human memory B cells primed by an MF59 adjuvanted prepandemic vaccine. 2009 Proc. Natl. Acad. Sci. U.S.A. pmid:19416838
Phillips CJ et al. Antibodies to squalene in US Navy Persian Gulf War veterans with chronic multisymptom illness. 2009 Vaccine pmid:19379786
Del Giudice G et al. Seasonal influenza vaccine provides priming for A/H1N1 immunization. 2009 Sci Transl Med pmid:20371459
Couvreur P ["Squalenoylation": a new approach to the design of anticancer and antiviral nanomedicines]. 2009 Bull. Acad. Natl. Med. pmid:19883017
Tong R et al. Stereo- and regioselective synthesis of squalene tetraepoxide. 2009 J. Org. Chem. pmid:19827774
Vesikari T et al. MF59-adjuvanted influenza vaccine (FLUAD) in children: safety and immunogenicity following a second year seasonal vaccination. 2009 Vaccine pmid:19840662
Kim ES et al. Squalene-induced exogenous lipoid pneumonia in an infant. 2009 Pediatr Int pmid:19799746
Laursen AB [Dangerous adjuvant in swine influenza vaccine]. 2009 Ugeskr. Laeg. pmid:19866499
Reddy LH and Couvreur P Squalene: A natural triterpene for use in disease management and therapy. 2009 Adv. Drug Deliv. Rev. pmid:19804806
Gerpe A et al. 5-Nitrofuranes and 5-nitrothiophenes with anti-Trypanosoma cruzi activity and ability to accumulate squalene. 2009 Bioorg. Med. Chem. pmid:19811923
Bildstein L et al. Freeze-drying of squalenoylated nucleoside analogue nanoparticles. 2009 Int J Pharm pmid:19782881
Fox CB Squalene emulsions for parenteral vaccine and drug delivery. 2009 Molecules pmid:19783926
Leszczynska A et al. Investigating the effects of statins on cellular lipid metabolism using a yeast expression system. 2009 PLoS ONE pmid:20041128